AG真人官方

Compass, Inc. filed a Form D reporting completion of a $501,897 private placement of Class A common stock under Rule 506(b). The shares were issued on 16 Jul 2025 to a single investor in satisfaction of a hold-back obligation from a prior acquisition; therefore the transaction is tied to a business-combination settlement rather than a new cash raise.

The New York-based Delaware corporation is classified as operating in the Residential AG真人官方 Estate industry and discloses annual revenue of over $100 million. Minimum outside investment was $10,000; no non-accredited investors participated. No sales commissions or finder鈥檚 fees were paid, and the issuer does not expect the offering to continue beyond one year.

Given the company鈥檚 revenue scale, the 0.5 million-dollar issuance appears immaterial and enables Compass to conserve cash while meeting acquisition-related obligations with negligible dilution.

Carvana Co. (CVNA) founder, CEO, director and 10% owner Ernest C. Garcia III filed a Form 4 for trades executed on 29 Jul 2025. Acting through two family trusts, he sold 5,766 Class A shares in 22 micro-tranches priced between $331.76 and $343.84 under a previously adopted Rule 10b5-1 plan (dated 13 Dec 2024). Estimated gross proceeds are roughly $1.95 million (VWAP 鈮� $337).

Post-sale holdings stand at about 601.5 k shares in the Ernest Irrevocable 2004 Trust and 701.4 k shares in the Multi-Generational Trust, leaving Garcia with an indirect stake of ~1.30 million shares. No derivative securities were transacted.

The filing reflects continued, systematic liquidity taking by the founder at elevated price levels. Although the 10b5-1 structure limits informational concerns, recurring insider sales can be interpreted as a moderately bearish sentiment signal for near-term investors.

Carvana Co. (CVNA) CEO, director and 10% owner Ernest C. Garcia III disclosed the indirect sale of 13,456 Class A shares on 28-29 Jul 2025 via two family trusts. Sale prices ranged from $328.20 to $338.66, implying gross proceeds of roughly $4.5 million. All dispositions were carried out under a Rule 10b5-1 plan adopted 13 Dec 2024, indicating the trades were pre-scheduled and not based on near-term corporate developments.

After these transactions, the Ernest Irrevocable 2004 Trust III holds about 604 k shares and the Ernest C. Garcia III Multi-Generational Trust III retains roughly 706 k shares, leaving Garcia鈥檚 combined indirect interest above 1.3 million shares. No derivative activity or changes in direct ownership were reported. While the dollar amount is modest relative to his remaining stake, the filing informs investors of ongoing insider selling and updates the beneficial ownership table. No operational or financial metrics were provided.

Alignment Healthcare (ALHC) Q2-25 10-Q highlights

Revenue climbed 49% year-over-year to $1.015 bn, driven by earned premiums of $1.006 bn. Medical expenses grew 46% to $881.7 m, but the medical loss ratio improvement helped swing operating results to a $22.7 m profit versus a $18.4 m loss in Q2-24. Net income attributable to shareholders reached $15.7 m, or $0.07 diluted EPS, reversing the prior-year $(0.13) loss.

For the first six months, revenue rose 48% to $1.94 bn with net income of $6.6 m. Cash and equivalents increased to $470.3 m, supporting total assets of $1.0 bn. Long-term debt stayed at $322.3 m after the Nov-24 issuance of 4.25% convertible notes; quarterly interest expense fell to $4.0 m. Stockholders鈥� equity improved to $141.0 m as the accumulated deficit narrowed.

Key ratios

• Operating margin: 2.2% vs (2.7)% YoY
• Medical expenses/Revenue: 86.9% vs 88.8%
• Cash & short-term investments: $505.8 m

Management noted an immaterial exit from the ACO REACH model effective 31-Dec-25 and confirmed compliance with all RBC/TNE capital rules. No new financial guidance was issued.

Kiniksa Pharmaceuticals International, plc (KNSA) has filed a Form 144 to notify the SEC of an intended insider sale.

• Shares to be sold: 64,508 common shares
• Aggregate market value: $1,928,595.68
• Approximate sale date: 07/30/2025
• Broker: Morgan Stanley Smith Barney LLC, New York
• Shares outstanding: 74,107,668

The shares were acquired the same day (07/30/2025) through the exercise of employee stock options under a registered plan and will be sold for cash. No other sales by this insider were reported in the past three months.

The proposed disposition equals roughly 0.09% of total shares outstanding, indicating a modest, routine-sized transaction rather than a large liquidation. The filer attests to having no undisclosed material adverse information and confirms compliance with Rule 10b5-1.

Carvana (CVNA) Form 4 鈥� insider activity

• Founder and 10%+ owner Ernest C. Garcia II exchanged 50,000 Class A units for Class A shares on 7/25/25 and another 50,000 on 7/28/25.
• All 100,000 newly issued Class A shares were immediately sold under a Rule 10b5-1 plan in 13 tranches at weighted-average prices of roughly $333-$339, generating 鈮� $33 million in gross proceeds.
• Each exchange triggered a one-for-one cancellation of Class B super-voting shares; Garcia鈥檚 direct Class B stake falls from 35.59 m to 35.44 m.

Post-transaction ownership

• Class A common: 0 shares held directly.
• Class B common: 35.44 m direct & 8.0 m indirect via ECG II SPE.
• Exchangeable Class A units: 44.30 m direct & 10.0 m indirect.

The sales provide liquidity to the founder and slightly reduce super-voting concentration, but they also represent sizable insider selling at elevated price levels, which some investors may view as a bearish signal. Garcia retains a controlling economic and voting interest.

Seagate Technology Holdings plc filed a Form 8-K dated 29 Jul 2025 to furnish its fiscal fourth-quarter and full-year 2025 results. The actual financial metrics are contained in the accompanying press release (Exhibit 99.1) and a separate Supplemental Financial Information deck posted on the Investor Relations site.

The Board declared a $0.72 per-share quarterly cash dividend, payable 9 Oct 2025 to shareholders of record on 30 Sep 2025. Management will host a webcast on 29 Jul 2025 at 2 p.m. PT / 5 p.m. ET to discuss the results and provide an outlook for fiscal 1Q 2026; a replay will remain available for approximately one year.

Items 2.02 and 7.01 are furnished鈥攏ot filed鈥攕o the information is not subject to Exchange Act Section 18 liability. No other material events were disclosed.

Carvana Co. (CVNA) CEO, Director and >10% owner Ernest C. Garcia III disclosed the sale of 10,000 Class A shares on 25 Jul 2025 through two family trusts operating under a Rule 10b5-1 trading plan adopted 13 Dec 2024. Each trust鈥擡rnest Irrevocable 2004 Trust III and Ernest C. Garcia III Multi-Generational Trust III鈥攕old 5,000 shares across 18 separate trades at volume-weighted average prices between $329.03 and $339.61, generating roughly $3.3 million in aggregate proceeds. Following the transactions, the Irrevocable Trust holds 611,440 shares and the Multi-Generational Trust holds 711,440 shares, leaving Garcia with an indirect stake of approximately 1.32 million shares. No derivative securities were exercised or disposed. The divestiture represents only about 0.75 % of the combined pre-sale holdings, appears routine, and does not alter Garcia鈥檚 control status.